The global Gaucher Disease Market is a specialized yet high-value segment of the orphan drug industry. Gaucher disease is a rare, autosomal recessive genetic disorder caused by a deficiency in the enzyme glucocerebrosidase. This deficiency leads to the harmful accumulation of fatty substances (glucocerebrosides) in the liver, spleen, bone marrow, and sometimes the nervous system. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/